Oct 2 (Reuters) - Pharmacolog I Uppsala AB (publ)
PHLOGb.ST :
* INTENDS TO IMPLEMENT COST REDUCTIONS
* INITIATING A COST-SAVING PROGRAM THAT WILL SIGNIFICANTLY
REDUCE
ONGOING OPERATING COSTS WHILE STREAMLINING COMPANY ORGANIZATION
TO SUPPORT EXISTING CUSTOMERS AND EXTERNAL DISTRIBUTORS
* IMPLEMENTATION OF COST-REDUCING MEASURES WILL START
IMMEDIATELY
AND WILL BE FULLY IMPLEMENTED BY JANUARY 2024
* AT FULL EFFECT, MEASURES WILL REDUCE OPERATING COSTS BY AT
LEAST
35% COMPARED TO OPERATING COSTS OF FULL YEAR 2022, THIS
CORRESPONDS TO A SUM OF AT LEAST SEK 10 MILLION
* DIRECT SALES EFFORTS HAVE NOT MET EXPECTATIONS OF COMPANY
AND
ITS SHAREHOLDERS
Source text for Eikon: ID:
Further company coverage: PHLOGb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))